Cmed reaches 20-year anniversary
Written by Cmed
Cmed was founded in 2000 and has since helped our sponsors deliver several hundreds of complex clinical trials spanning all phases. While we continue to provide Data & Analytics solutions and an exceptional technology offering with encapsia, we have also flourished as a global full service, technology-led CRO.
Cmed’s strong expertise, systems and collaborative approach have been at the heart of the company’s growth. Our team has a wealth of experience from exposure to a wide range of study designs. With 100% of our team experienced in oncology, our talented people deliver oncology, immuno-oncology and rare diseases clinical trials.
Our practical experience of clinical trials has been harnessed into the development of encapsia, the game-changing clinical data suite. It allows the capture, management and real-time review of all clinical trial data within one platform, including EDC, eSource and third-party data.
To mark our 20-year anniversary, we are renewing our commitment to deliver results to the highest quality and help bring life-saving medicines to market.